Cigna Group (CI) Stock Analysis
Free AI-powered analysis and research for Cigna Group stock
Sector: Healthcare
CI snapshot
Data as of 3 Nov 2026 close. Updated daily.
Cigna Group scores 53/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 73% of its 52-week range, up 14.2% over the past year. Latest reported figures show a profit margin of 2.3%, return on equity of 16.8% and revenue growth of +6.7%.
What is driving the score
- RSI Neutral: +5
- Uptrend: +5
- MACD Bearish: -8
- Low P/E (12.3): +10
- Weak Profit Margin (2.3%): -8
- Low Liquidity (0.85 Current Ratio): -10
- Strong ROE (16.8%): +5
- Above MA200: +4
- Up Over 1 Year (+14.2%): +3
- Low Volume (0.3x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full CI report
Cigna Group (CI) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze CI Now βπ° Latest Update
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings
Mon, November 2, 2026 at 1:15 PM UTC 2 min read
Analysts project Cigna (CI) will report Q3 earnings of $7.46 per share, reflecting a 4.7% year-over-year decline, with revenues expected to reach $73.53 billion, a 5.7% increase from the previous year. Key metrics indicate growth in various segments, including Evernorth Health Services and Cigna Healthcare premiums, while the Medical Care Ratio is estimated at 85.1%. Cigna's shares have risen 10.2% over the past month, outperforming the S&P 500's decline of 0.9%.